| Session 4: Pancreatic Cancer |
| 13:40–14:10 |
Application of Nanoparticle in Pancreatic Cancer Treatment: Current Problems and Future Prospects |
Dr. Wen-Pin Su蘇文彬 副教授Institute of Clinical Medicine, National Cheng Kung University, Taiwan |
| 14:10–14:40 |
The Role of Molecular Medicine in Pancreatic Cancer |
Dr. Li-Tzong Chen陳立宗 特聘研究員National Institute of Cancer Research, National Health Research Institutes, Taiwan |
| 14:40–15:10 |
Precision Oncology in Surgery: Patient Selection for Operable Pancreatic Cancer |
Dr. David K. ChangInstitute of Cancer Sciences, University of Glasgow, U.K. |
| Session 5: Lung Cancer |
| 15:30–16:00 |
The Feasibility of Low Dose CT Lung Cancer Screening in Taiwan: Perspective of Radiologists |
Dr. Yeun-Chung Chang張允中 教授Department of Medical Imaging, National Taiwan University Hospital, Taiwan |
| 16:00–16:30 |
Advances in Surgery for Early Lung Cancer |
Dr. Jin-Shing Chen陳晉興 副院長National Taiwan University Cancer Center, National Taiwan University Hospital, Taiwan |
| 16:30–17:00 |
Current Challenge of Lung Cancer Precision Therapy in resectable NSCLC |
Dr. Gee-Chen Chang張基晟 副校長Chung Shan Medical University, Taiwan |
| 17:00–17:10 |
Closing Remarks |
Dr. Huey-Kang Sytwu司徒惠康 副院長National Health Research Institutes, Taiwan |